BUDAPEST: Hungarian pharmaceutical company Béres Gyógyszergyár will invest HUF 3.2 bln at its unit in Szolnok, central Hungary, with HUF 1.6 bln being derived from government funding, Hungaryʼs foreign minister Péter Szijjártó said yesterday, according to Hungarian news agency MTI.
Béres will increase production capacity, add 1,600 sqm to its production area and 400 sqm to its logistics warehouse, install new technology, develop the infrastructure and create 60 new jobs, Szijjártó said. Chairman József Béres, whose father invented the companyʼs flagship product, said Béres Gyógyszergyár has so far invested HUF 3.3 bln at its Szolnok unit, acquired in 1995. The company employs 340 including the 215 at the Szolnok plant.
The company has funded its developments primarily from internal sources, supplemented with HUF 296 mln in government funding obtained through tenders. Béres Gyógyszergyár, founded as a family business 25 years ago, is known in Hungary for manufacturing immune boosters. It controls 35% of that market, Béres said.
